Hundreds Running to Help HERA

April 16, 2013

Hundreds Lace Up Their Running Shoes on Mother’s Day to  Fight Ovarian Cancer

Denver’s Mother’s Day 5K Announces Partnership with HERA Women’s Cancer Foundation

DENVER April 17, 2013 – The Mother’s Day 5k, scheduled for May 12 at Denver’s City Park, has announced a partnership with the HERA Women’s Cancer Foundation, a nationally recognized ovarian cancer nonprofit whose mission is to stop the loss of women from ovarian cancer through Health, Empowerment, Research and Awareness. A portion of every registration for the race will go directly to HERA, and participants will have the opportunity to raise additional funds for the organization.

“Mother’s Day is the perfect time to raise awareness of ovarian cancer and for families to become more aware of the signs and symptoms of the disease to aid in early detection,” said Meg Steitz, HERA’s executive director. “We are honored to be selected as the charitable partner, and invite runners, joggers, walkers of all ages and paces to join us this Mother’s Day.”

Of the funds HERA raises through events like the Mother’s Day 5k, 88 percent provides for HERA’s programs such as cutting-edge research grants to scientists at respected medical institutions around the country like the Johns Hopkins University, the MD Anderson Cancer Center, the University of Colorado, and others. In addition, the organization awards grants to local community groups raising awareness about the disease.

“I’m excited to run this race and raise money for much-needed research on ovarian cancer,” said Boulder resident Maggie Luck. “As a four-and-a-half-year survivor, I am grateful that I have made it this far, but sad at how slowly we are making any real progress against this disease. HERA is a shining light in funding new research and awareness, and provides hope that we can conquer this disease.”

Registration for the Mother’s Day 5k is open through Friday, May 10 at 5 p.m. at: Individual registration is $35 and a family rate for up to four people is $115. All registrations include a t-shirt and all-day admission to the Denver Zoo on Mother’s Day.

According to the American Cancer Society, one in 72 women will be diagnosed with ovarian cancer in her lifetime. In 2013, it is estimated that about 22,240 women will receive a new diagnosis of ovarian cancer and about 14,230 women will die from the disease. With early detection, about 94 percent will survive longer than five years after diagnosis. Currently, however, only 20 percent of ovarian cancer is caught early. It ranks fifth as the cause of cancer deaths in women and accounts for more deaths than any other cancer of the female reproductive system.

About the HERA Foundation:

Established in 2002, the HERA Women’s Cancer Foundation is a 501(c)(3) nonprofit organization whose mission is to stop the loss of women from ovarian cancer by promoting Health, Empowerment, Research, and Awareness. As a nationally recognized ovarian cancer organization, HERA provides funding for cutting-edge research grants to scientists at respected medical institutions. In so doing, HERA attracts more young researchers to expand the scientific understanding of ovarian cancer while improving the lives of those battling the disease. In addition, HERA awards grants to local community groups to raise awareness about the disease in novel and unusual ways. More information is available at

news image strip